Key facts
- INNITIUS’s last known valuation is $9.7M (Sep 2023).
- It has raised $8.9M.
- Notable investors include European Innovation Council, Clave (Pamplona), Seed Capital Bizkaia, Clave Capital, Banco Santander — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for INNITIUS
- ·The full record, as it builds
Funding rounds
No funding rounds for INNITIUS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About INNITIUS
Developer of actionable diagnostic devices designed to improve women's health through the use of torsional waves. The company's devices utilize a patented intravaginal probe to transmit torsional waves for the diagnosis of conditions associated with changes in tissue consistency and threatened preterm labor events, enabling medical practitioners to detect false indications of premature birth.
- Sector
- Healthcare
- HQ
- Bilbao, Spain
- Founded
- 2018
- Employees
- 27
- Website
- innitius.com/
- Ownership
- Privately Held (backing)
INNITIUS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in INNITIUS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on INNITIUS in its N-PORT filings yet. We sweep new filings monthly.